• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Hoya introduces Sensity, light reactive lenses

Article

Hoya recently introduced its new photochromic lenses, Hoya Sensity featuring Stabilight Technology, which the company says helps the lenses perform consistently in different climates and seasons.

Uithoorn, Netherlands-Hoya recently introduced its new photochromic lenses, Hoya Sensity featuring Stabilight Technology, which the company says helps the lenses perform consistently in different climates and seasons.

Hoya says the Hoya Sensity lens darkens up to 45 percent in 90 seconds, but the lens also fade back to full clarity quickly, lightening up to 23 percent after one minute, all while maintaining UV protection.

The company says the lenses are made using its Photochromic Precision Technology, a “microscopically accurate spin coating process tailored to freeform lens production” which ensures an even distribution of molecules over the entire lens surface.

Hoya Sensity can be supplied in all Hoya single vision, bifocal, and progressive lens designs. It can also be combined with Hoya premium coatings and comes in several stock options. The lenses are available in Bronze Brown and Silver Grey. 

Next: Adlens presents Adlens Sundials

DrFirst, My Vision Express partner to deliver comprehensive e-Rx to ECPs

Avellino launches DNA test for LASIK safety

Related Videos
World Optometry Day 2024
Nicholas Gilberg, OD, gives a tutorial on EssilorLuxottica's Leonardo team practice management programs
Chris and Jamie Shyer, Zyloware Eyewear co-CEOs, after their NOW Optical Lifetime Achievement award win at Vision Expo East
Jessica Steen, OD, FAAO, discusses systemic medication and ocular adverse effects at Vision Expo East 2024
At Vision Expo East 2024, Srinivas Kondapalli, MD, demonstrates how to use Rinsada to address ocular surface disease.
Brujic at Rinsada Booth at Vision Expo East 2024
© 2024 MJH Life Sciences

All rights reserved.